Human Genome Epidemiology Literature Finder
|
Records 1 - 23 (of 23 Records) |
| Query Trace: Hepatitis B and CTNNB1[original query] |
|---|
| Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes. Journal of gastrointestinal cancer 2011 Mar 42 (1): 20-5. Vivekanandan Perumal, Torbenson Michael, Ramakrishna Banumat |
| Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand. Hepatitis research and treatment 2011 2011 697162. Galy Olivier, Chemin Isabelle, Le Roux Emilie, Villar Stéphanie, Le Calvez-Kelm Florence, Lereau Myriam, Gouas Doriane, Vieco Beatriz, Suarez Iris, Navas Maria-Cristina, Chevallier Michèle, Norder Helene, Srivatanakul Petcharin, Karalak Anant, Sangrajrang Suleeporn, Trépo Christian, Hainaut Pier |
| Somatic changes in primary liver cancer in Russia: a pilot study. Mutation research 2013 Aug 755 (2): 90-9. Kalinina Olga, Marchio Agnès, Urbanskii Aleksandr I, Tarkova Aleksandra B, Rebbani Khadija, Granov Dmitri A, Dejean Anne, Generalov Mikhail I, Pineau Pasc |
| Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics 2013 Aug 102 (2): 74-83. Tornesello Maria Lina, Buonaguro Luigi, Tatangelo Fabiana, Botti Gerardo, Izzo Francesco, Buonaguro Franco |
| ß-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma. Oncology 2014 87 (3): 159-66. Lu Li-Chun, Shao Yu-Yun, Lee Yi-Hsuan, Hsieh Min-Shu, Hsiao Chi-Huang, Lin Hsiao-Hui, Kao Hsiang-Fong, Ma Yu-Yi, Yen Feng-Chu, Cheng Ann-Lii, Hsu Chih-Hu |
| Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. Oncotarget 2014 May 5 (10): 3012-22. Janku Filip, Kaseb Ahmed O, Tsimberidou Apostolia M, Wolff Robert A, Kurzrock Razel |
| Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation. PloS one 2014 9 (5): e95307. Ding Xiao, Yang Yuan, Han Baoda, Du Chengzhi, Xu Naiqing, Huang Huanwei, Cai Tao, Zhang Aiqun, Han Ze-Guang, Zhou Weiping, Chen Lia |
| Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia. Annals of hepatology 0 14 (1): 64-74. Suarez M Iris, Uribe Diego, Jaramillo Carlos M, Osorio German, Perez Juan C, Lopez Rocio, Hoyos Sergio, Hainaut Pierre, Pineau Pascal, Navas Maria |
| Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection. Cancer genetics 2015 Jul . Saitta Carlo, Lanza Marika, Bertuccio Antonio, Lazzara Salvatore, Navarra Giuseppe, Raimondo Giovanni, Pollicino Tere |
| Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma. Oncotarget 2016 Sep . Lee Seung Eun, Chang Seong-Hwan, Kim Wook Youn, Lim So Dug, Kim Wan Seop, Hwang Tea Sook, Han Hye Seu |
| Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma. Oncotarget 2016 Jun . Pezzuto Francesca, Izzo Francesco, Buonaguro Luigi, Annunziata Clorinda, Tatangelo Fabiana, Botti Gerardo, Buonaguro Franco M, Tornesello Maria Li |
| Genetic polymorphisms in the Wnt/ß-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma. Clinical biochemistry 2016 Mar . Kim Soon Sun, Cho Hyo Jung, Lee Hyun-Young, Park Ju Han, Noh Choong Kyun, Shin Sung Jae, Lee Kee Myung, Yoo Byung Moo, Lee Kwang Jae, Cho Sung Won, Cheong Jae Yo |
| Influence of polymorphisms in the Wnt/ß-catenin pathway genes on hepatocellular carcinoma risk in a Chinese Han population. Medicine 2017 Mar 96 (12): e6127. Li Qing-Min, Zhang Feng-Qin, Li Ya-Feng, Xian Qing-Jie, Zhang Yan-Qiang, Li Pe |
| Clinicopathologic characteristics of Wnt/?-catenin-deregulated hepatocellular carcinoma. Indian journal of cancer 2018 8 54 (4): 634-639. Verma Anuj, Bal Munita, Ramadwar Mukta, Deodhar Kedar, Patil Prachi, Goel Mahe |
| Keratin 19-expressing hepatocellular carcinoma and small-duct type intrahepatic cholangiocarcinoma show a similar postoperative clinical course but have distinct genetic features. Histopathology 2019 4 75 (3): 385-393. Akita Masayuki, Ajiki Tetsuo, Fukumoto Takumi, Itoh Tomoo, Zen Y |
| Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study. Liver cancer 2019 3 8 (1): 12-23. Kang Hyo Jeong, Haq Farhan, Sung Chang Ohk, Choi Jene, Hong Seung-Mo, Eo Soo-Heang, Jeong Hui Jeong, Shin Jinho, Shim Ju Hyun, Lee Han Chu, An Jihyun, Kim Mi-Ju, Kim Kyu-Pyo, Ahn Sung-Min, Yu Euns |
| Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. Cell 2019 10 179 (2): 561-577.e22. Gao Qiang, Zhu Hongwen, Dong Liangqing, Shi Weiwei, Chen Ran, Song Zhijian, Huang Chen, Li Junqiang, Dong Xiaowei, Zhou Yanting, Liu Qian, Ma Lijie, Wang Xiaoying, Zhou Jian, Liu Yansheng, Boja Emily, Robles Ana I, Ma Weiping, Wang Pei, Li Yize, Ding Li, Wen Bo, Zhang Bing, Rodriguez Henry, Gao Daming, Zhou Hu, Fan J |
| Investigation of CTNNB1 gene mutations and expression in hepatocellular carcinoma and cirrhosis in association with hepatitis B virus infection. Infectious agents and cancer 2020 6 15 37. Javanmard Davod, Najafi Mohammad, Babaei Mohammad Reza, Karbalaie Niya Mohammad Hadi, Esghaei Maryam, Panahi Mahshid, Safarnezhad Tameshkel Fahimeh, Tavakoli Ahmad, Jazayeri Seyed Mohammad, Ghaffari Hadi, Ataei-Pirkooh Angila, Monavari Seyed Hamidreaz, Bokharaei-Salim Far |
| Integrative analysis of highly mutated genes in hepatitis B virus-related hepatic carcinoma. Cancer medicine 2020 2 9 (7): 2462-2479. Kong Fanyun, Kong Delong, Yang Xiaoying, Yuan Dongchen, Zhang Ning, Hua Xuan, You Hongjuan, Zheng Kuiyang, Tang Renxi |
| Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. Hepatobiliary surgery and nutrition 2021 Apr 10 (2): 172-179. Wang Shuo, Shi Huasheng, Liu Tao, Li Manjiang, Zhou Sanshun, Qiu Xuan, Wang Zusen, Hu Weiyu, Guo Weidong, Chen Xiaoqian, Guo Honglin, Shi Xiaoliang, Shi Junping, Zang Yunjin, Cao Jingyu, Wu Liq |
| Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma. BMC cancer 2022 Oct 22 (1): 1046. Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Ito Takaaki, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Otsuka Shimpei, Ohnami Sumiko, Nagashima Takeshi, Hatakeyama Keiichi, Sugino Takashi, Urakami Kenichi, Akiyama Yasuto, Yamaguchi K |
| CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes. Journal of viral hepatitis 2023 9 . Qiqi Ning, Tongwang Yang, Xianghua Guo, Yanxiang Huang, Yuxue Gao, Mengcheng Liu, Pengxiang Yang, Yuanyue Guan, Ning Liu, Yang Wang, Dexi Ch |
| Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma. Frontiers in genetics 2023 8 14 1235260. Sonu Kumar, Neeti Nadda, Afnan Quadri, Rahul Kumar, Shashi Paul, Pranay Tanwar, Shivanand Gamanagatti, Nihar Ranjan Dash, Anoop Saraya, Shalimar, Baibaswata Nay |
- Page last reviewed:Feb 1, 2024
- Content source: